Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and Hepatitis C, Chronic

pyrazines has been researched along with Hepatitis C, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yanai, H2

Other Studies

2 other study(ies) available for pyrazines and Hepatitis C, Chronic

ArticleYear
Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2014, Volume: 13, Issue:5

    Topics: Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Pyrazines; Triazoles

2014
Sitagliptin in treatment of diabetes complicated by chronic hepatitis C.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2010, Volume: 9, Issue:4

    Topics: Blood Glucose; Comorbidity; Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2010